893420-19-4

Basic information

• Product Name: 4-Bromo-2-chloro-N,N-dimethylbenzamide
• Synonyms: 4-Bromo-2-chloro-N,N-dimethylbenzamide;N,N-Dimethyl 4-bromo-2-chlorobenzamide
• CAS NO: 893420-19-4
• Molecular Formula: C₉H₉BrClNO
• Molecular Weight: 262.53086
• Mol File: 893420-19-4.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4-Bromo-2-chloro-N,N-dimethylbenzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Bromo-2-chloro-N,N-dimethylbenzamide(893420-19-4)
• EPA Substance Registry System: 4-Bromo-2-chloro-N,N-dimethylbenzamide(893420-19-4)

Safety Data

• Hazardous Substances Data: 893420-19-4(Hazardous Substances Data)

Usage

General Description

4-Bromo-2-chloro-N,N-dimethylbenzamide is a chemical compound with the molecular formula C9H10BrClN2O. It is an amide derivative with two substituent groups, bromo- and chloro-, on the benzene ring. 4-Bromo-2-chloro-N,N-dimethylbenzamide is commonly used in organic synthesis and as an intermediate in the manufacture of pharmaceuticals and agrochemicals. It has been studied for its potential applications in the field of medicinal chemistry, particularly in the development of new drugs for various therapeutic purposes. The compound's structure and properties make it a valuable building block for the synthesis of more complex molecules, making it an important chemical in the field of organic chemistry.

Upstream product

• 59748-90-2 4-Bromo-2-chloro-benzoic Acid 
• 506-59-2 N,N-dimethylammonium chloride 
• 124-40-3 dimethyl amine 

Relevant articles and documents

HOMOBISPIPERIDINYL DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, COMPOSITIONS, AND THEIR USE

In its many embodiments, the present invention provides certain substituted bispiperidinyl compounds of the Formula (I): and pharmaceutically acceptable salts thereof, wherein ring A, ring B, R1, R2, R3, L, R4, X, Z, Li, Q and R5 are as defined herein. The novel compounds of the invention, and pharmaceutically acceptable compositions comprising a compound thereof, are useful as Liver Χ-β receptor (LXRβ) agonists, and may be useful for treating or preventing pathologies related thereto. Such pathologies include, but are not limited to, inflammatory diseases and diseases characterized by defects in cholesterol and lipid metabolism, such as Alzheimer's disease.

4- (4- (IMIDAZOL-4-YL) PYRIMIDIN-2-YLAMINO) BENZAMIDES AS CDK INHIBITORS

Compounds of the formula: (I): wherein variable groups are as defined within and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man.